The diabetes care devices are the medical devices used to monitor the glucose levels in the blood of the diabetes patients. The monitoring devices are known as continuous glucose monitoring devices or glucometers. The other diabetes care devices are used to deliver insulin in the body, these devices are used by the diabetes patients who are unable to produce insulin by their own. The insulin delivery devices include pumps, syringes, pens, and others.

According to our latest study, "Diabetes Care Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type and End User," the market is projected to grow from US$ 28,942.1 million in 2022 to US$ 42,119.3 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2022 to 2028. The market's growth can be attributed to the robustly rising prevalence of diabetes and increasing support by the government in the US. In the US, diabetes is among the most common and expensive chronic diseases. The highest rate of diabetes is commonly seen in the elder population. However, the rise in the prevalence of diabetes continues across the US, and it is also being seen among the overweight and obese population.

Based on end user, the global diabetes care devices market is segmented into homecare and hospitals & clinics. In 2022, the homecare segment would hold a larger market share. In addition, the segment is also expected to grow at a faster rate in the coming years, owing to the rise in the prevalence of diabetes and the use of the device in making patients independent in terms of managing and monitoring their diabetes. The homecare segment is majorly driven by diabetes patients with type 1 diabetes. The prevalence of type 1 diabetes patients is fueling the demand for diabetes care devices.  According to the Centers for Disease Control and Prevention's (CDC) data for 2020, approximately 34.2 million people of all ages—or 10.5% of the US population had diabetes. Furthermore, according to the International Diabetes Federation (IDF) 2019, approximately 425 million people are estimated to suffer from diabetes worldwide. Moreover, the International Diabetes Federation projected that people living with type 1 diabetes represent approximately 10% of the diabetes population worldwide. Therefore, the factors mentioned above are likely to propel the market's growth during the forecast period.

Get Sample PDF at @ https://www.theinsightpartners.com/sample/TIPRE00003753/

The Diabetes Care Devices market majorly consists of the players such as BD; Novo Nordisk A/S; Medtronic; B. Braun Melsungen AG; Tandem Diabetes Care Inc.; Insulet Corporation; Eli Lilly and Company; Dexcom, Inc.; Terumo Corporation; F. Hoffmann-LA Roche LTD among others. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized strategies such as product launches, expansions, and product upgradations for the growth of their organizations. The companies have adopted several inorganic and organic strategies to accelerate their growth and improve their market position.

Get Report Sample - https://www.theinsightpartners.com/reports/diabetes-care-devices-market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876